Comparing clinical outcomes in HIV-infected and uninfected older men hospitalized with community-acquired pneumonia

HIV Medicine

Volumn 16, Issue 7, 2015, Pages 421-430

  Barakat, Lydia A ^a   Juthani Mehta, M ^a   Allore, H ^a   Trentalange, M ^a   Tate, J ^b   Rimland, D ^c   Pisani, M ^a   Akgun K M ^a,b   Goetz, M B ^d   Butt, A A ^e   Rodriguez Barradas, M ^f   Duggal, M ^b   Crothers, K ^g   Justice, A C ^a,b   Quagliarello, V J ^a  

^a YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b VA CONNECTICUT HEALTHCARE SYSTEM   (United States)

^c ATLANTA VA MEDICAL CENTER   (United States)

^d VA GREATER LOS ANGELES HEALTHCARE SYSTEM   (United States)

^e UNIVERSITY OF PITTSBURGH   (United States)

^f MICHAEL E DEBAKEY VETERANS AFFAIRS MEDICAL CENTER   (United States)

^g UNIVERSITY OF WASHINGTON   (United States)

Author keywords

HIV; Outcomes; Pneumonia

Indexed keywords

AMOXICILLIN PLUS CLAVULANIC ACID; ANTI HUMAN IMMUNODEFICIENCY VIRUS AGENT; AZITHROMYCIN; CEFACLOR; CEFAMANDOLE; CEFEPIME; CEFOTAXIME; CEFPODOXIME; CEFTAZIDIME; CEFTRIAXONE; CEFUROXIME; CLARITHROMYCIN; ERYTHROMYCIN; GATIFLOXACIN; LEVOFLOXACIN; LINEZOLID; MOXIFLOXACIN; OFLOXACIN; PIPERACILLIN; SULTAMICILLIN; TICARCILLIN; VANCOMYCIN; BIOLOGICAL MARKER;

ADULT; AGED; ANTIBIOTIC THERAPY; ANTIVIRAL THERAPY; ARTICLE; COMMUNITY ACQUIRED PNEUMONIA; CONTROLLED STUDY; FEMALE; HOSPITAL PATIENT; HOSPITAL READMISSION; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTED PATIENT; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; LENGTH OF STAY; MAJOR CLINICAL STUDY; MALE; MIDDLE AGED; MORTALITY; OUTCOME ASSESSMENT; PRIORITY JOURNAL; VETERAN; AIDS RELATED COMPLEX; COMMUNITY ACQUIRED INFECTION; COMPARATIVE STUDY; COMPLICATION; EPIDEMIOLOGY; IMMUNOLOGY; LONGITUDINAL STUDY; PNEUMONIA; STATISTICS AND NUMERICAL DATA; SURVIVAL ANALYSIS; UNITED STATES;

AIDS-RELATED OPPORTUNISTIC INFECTIONS; BIOMARKERS; COMMUNITY-ACQUIRED INFECTIONS; HIV INFECTIONS; HUMANS; LENGTH OF STAY; LONGITUDINAL STUDIES; MALE; MIDDLE AGED; PATIENT READMISSION; PNEUMONIA; SURVIVAL ANALYSIS; UNITED STATES; VETERANS;

EID: 84949320979     PISSN: 14642662     EISSN: 14681293     Source Type: Journal    
DOI: 10.1111/hiv.12244     Document Type: Article

References (40)

1. Brooks JT, Buchacz K, Gebo KA, Mermin J. HIV infection and older Americans: the public perspective. Am J Public Health 2012; 102: 1516-1526.
2. The CASCADE Collaboration. Survival after introduction of HAART in people with known duration of HIV-1 infection. Lancet 2000; 355: 1158-1159.
3. Center of Disease Control and Prevention. HIV Surveillance Report 2011; Vol. 23.
4. WolffAJ, O'Donnell AE. Pulmonary manifestations of HIV infection in the era of highly active antiretroviral therapy. Chest 2001; 120: 1888-1893.
5. Crothers K, Thompson BW, Burkardt K etal. HIV-associated lung infections and complications in the era of combination antiretroviral therapy. Proc Am Thorac Soc 2011; 8: 275-281.
6. Murray JF, Felton CP, Garay SM etal. Pulmonary complications of the acquired immunodeficiency syndrome. N Engl J Med 1984; 310: 1682-1688.
7. Bartlett JG. Pneumonia in the patient with HIV infection. Infect Dis Clin North Am 1998; 12: 807-820.
8. Meduri GU, Stein DS. Pulmonary manifestations of acquired immunodeficiency syndrome. Clin Infect Dis 1992; 14: 98-113.
9. Madeddu G, Porqueddo EM, Cambosu F etal. Bacterial community acquired pneumonia in HIV-infected inpatients in the highly active antiretroviral therapy era. Infection 2008; 36: 231-236.
10. Curran A, Falco V, Crespo M etal. Bacterial pneumonia in HIV-infected patients: use of the pneumonia severity index and impact of current management on incidence, aetiology and outcome. HIV Med 2008; 9: 609-615.
11. Tumbarello M, Tacconelli E, de Gaetano K etal. Bacterial pneumonia in HIV-infected patients: analysis of risk factors and prognostic indicators. J Acquir Immune Defic Syndr Hum Retrovirol 1998; 18: 39-45.
12. Chew KW, Yen IH, Li JZ, Winston LG. Predictors of pneumonia severity in HIV-infected adults admitted to an urban public hospital. AIDS Patient Care STD 2011; 25: 273-277.
13. Malinis M, Myers J, Bordon J etal. Clinical outcomes of HIV-infected patients hospitalized with bacterial community-acquired pneumonia. Int J Infect Dis 2010; 14: e22-e27.
14. Feldman C, Klugman KP, Yu VL etal. Bacteremic pneumococcal pneumonia: impact of HIV on clinical presentation and outcome. J Infect 2007; 55: 125-135.
15. Neiderman MS, Mandell LA, Anzueto A etal. Guidelines for the management of adults with community-acquired pneumonia. Am J Respir Crit Care Med 2001; 163: 1730-1754.
16. Hirschtick RE, Glassroth J, Jordan MC etal. Bacterial pneumonia in persons infected with human immunodeficiency virus. N Engl J Med 1995; 333: 845-851.
17. Christensen D, Feldman C, Rossi P etal. HIV infection does not influence clinical outcomes in hospitalized patients with bacterial community-acquired pneumonia: results from the CAPO international cohort study. Clin Infect Dis 2005; 41: 554-556.
18. Bartlett JG, Breiman RF, Mandell LA, File TM. Community-acquired pneumonia in adults: guidelines for management. Clin Infect Dis 1998; 26: 811-838.
19. Mandell LA, Wunderink RG, Azueto A etal. Infectious Disease Society of America/American Thoracic Society consensus guidelines on the management of community-acquired pneumonia in adults. Clin Infect Dis 2007; 44 (Suppl 2): S27-S72.
20. Fultz SL, Skanderson M, Mole LA etal. Development and verification of a 'virtual' cohort using the National VA Health Information System. Med Care 2006; 44 (8 Suppl 2): S25-S30.
21. Tate JP, Justice AC, Hughes MD etal. An internationally generalizable risk index for mortality after one year of antiretroviral therapy. AIDS 2013; 27: 563-572.
22. Justice AC, Modur SP, Tate JP etal. for the NA-ACCORD and VACS Project Teams. Predictive Accuracy of the Veterans Aging Cohort Study index for mortality with HIV infection: a North American cross cohort analysis. J Acquir Immune Defic Syndr 2013; 62: 149-163.
23. Akgün KM, Tate JP, Pisani M etal. Medical ICU admission diagnoses and outcomes in human immunodeficiency virus-infected and virus-uninfected veterans in the combination antiretroviral era. Crit Care Med 2013; 41: 1458-1467.
24. Justice AC, Freiberg MS, Tracy R etal. Does an index composed of clinical data reflect effects of inflammation, coagulation, and monocyte activation on mortality among those aging with HIV? Clin Infect Dis 2012; 54: 984-994.
25. Aronsky D, Haug PJ, Lagor C, Dean NC. Accuracy of administrative data for identifying patients with pneumonia. Am J Med Qual 2005; 20: 319-328.
26. Perez JL, Moore RD. Greater effect of highly active antiretroviral therapy on survival in people aged >or =50 years compared with younger people in an urban observational cohort. Clin Infect Dis 2003; 36: 212-218.
27. Shah S, Mildvan D. HIV and aging. Curr Infect Dis Rep 2006; 8: 241-247.
28. Effros RB, Fletcher CV, Gebo K etal. Workshop on HIV infection and aging: what is known and future research directions. Clin Infect Dis 2008; 47: 542-553.
29. Crothers K, Huang L, Goulet JL etal. HIV infection and risk for incident pulmonary disease in the combination antiretroviral therapy era. Am J Respir Crit Care Med 2011; 183: 388-395.
30. Goulet JL, Fultz S, Rimland D etal. Do patterns of comorbidity vary by HIV status, age, and HIV severity? Clin Infect Dis 2007; 45: 1593-1601.
31. Backus LI, Boothroyd DB, Phillips BR etal. National Quality Forum performance measures for HIV/AIDS care: the Department of Veterans Affairs' experience. Arch Intern Med 2010; 170: 1239-1246.
32. Justice AC. HIV and aging: time for a new paradigm. Curr HIV/AIDS Rep 2010; 7: 69-76.
33. Polsky B, Gold JWM, Whimbey E etal. Bacterial pneumonia in patients with the acquired immunodeficiency syndrome. Ann Intern Med 1986; 104: 38-41.
34. Frankel RE, Virata M, Hardalo C, Altice FL, Friedland G. Invasive pneumococcal disease: clinical features, serotypes, and antimicrobial resistance patterns in cases involving patients with and without Human Immunodeficiency Virus Infection. Clin Infect Dis 1996; 23: 577-584.
35. Baril L, Astagneau P, Nguyen J etal. Pyogenic bacterial pneumonia in human immunodeficiency virus-infected inpatients: a clinical, radiological, microbiological, and epidemiological study. Clin Infect Dis 1998; 26: 964-971.
36. Rimland D, Navin TR, Lennox JL etal. Prospective study of etiologic agents of community-acquired pneumonia in patients with HIV infection. AIDS 2002; 16: 85-95.
37. Wallace JM, Rao AV, Glassroth J etal. Respiratory illness in persons with human immunodeficiency virus infection. Am Rev Respir Dis 1993; 148: 1523-1529.
38. Viale P, Scudeller L, Signorini L etal. HIV- associated community-acquired pneumonia in the highly active antiretroviral therapy era. AIDS 2002; 16: 2361-2362.
39. Hull MW, Phillips P, Montaner JSG. Changing global epidemiology of pulmonary manifestations of HIV/AIDS. Chest 2008; 134: 1287-1298.
40. Rodriguez-Barradas MC, Goulet J, Brown S etal. Impact of pneumococcal vaccination on the incidence of pneumonia by HIV infection status among patients enrolled in the veterans aging cohort 5-site study. Clin Infect Dis 2008; 46: 1093-1100.